Zobrazeno 1 - 10
of 89
pro vyhledávání: '"YO-CHEN CHANG"'
Autor:
Yo-Chen Chang, Tzu-En Kao, Ching-Long Chen, Yu-Chih Lin, De-Kuang Hwang, Yih-Shiou Hwang, Chun-Ju Lin, Wei-Chun Chan, Chang-Ping Lin, San-Ni Chen, Shwu-Jiuan Sheu
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractPurpose To offer consensus on the utilization of corticosteroids (CS) for treating non-infectious uveitis in the context of clinical practice in Taiwan. This entails examining the different administration methods, their advantages and disadva
Externí odkaz:
https://doaj.org/article/fc7b4e9f92d149f680731388fc070049
Publikováno v:
Reports, Vol 7, Iss 1, p 19 (2024)
We present an unusual case of uveitis secondary to avelumab and pembrolizumab in a 39-year-old Taiwanese male with stage IV clear cell renal cell carcinoma (ccRCC) and lung metastasis, who initially received pembrolizumab as his primary treatment. Ho
Externí odkaz:
https://doaj.org/article/18e6ef8398494f749a6e469db09704d9
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 39, Iss 12, Pp 1245-1246 (2023)
Externí odkaz:
https://doaj.org/article/0e2ac7292cb743ffa07b1e6de407c69e
Autor:
De-Kuang Hwang, Jia-Horung Hung, Yo-Chen Chang, Ching-Long Chen, San-Ni Chen, Cheng-Kuo Cheng, Yih-Shiou Hwang, Hsi-Kung Kuo, An-Fei Li, Chun-Ju Lin, Chang-Hao Yang, Shwu-Jiuan Sheu, Chang-Ping Lin
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 55, Iss 4, Pp 573-580 (2022)
Uveitis is a sight-threatening disease that can be associated with many different etiologies. Successful treatment of uveitis relies on accurate diagnosis and prompt efficient therapy. History taking, physical and ocular examinations, systemic evalua
Externí odkaz:
https://doaj.org/article/53d42ca4fe904acfac963745338f7c6f
Autor:
Po-Yen Lee, Yu-Hung Lai, Po-Len Liu, Ching-Chih Liu, Chia-Cheng Su, Fang-Yen Chiu, Wei-Chung Cheng, Shiuh-Liang Hsu, Kai-Chun Cheng, Li-Yi Chiu, Tzu-En Kao, Chia-Ching Lin, Yo-Chen Chang, Shu-Chi Wang, Chia-Yang Li
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
Abstract Amantadine hydrochloride (HCl) is commonly prescribed for treating influenza A virus infection and Parkinson’s disease. Recently, several studies have indicated that the use of amantadine HCl is associated with corneal edema; however, the
Externí odkaz:
https://doaj.org/article/4685db666c914a6b81d9725b14670eba
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 38, Iss 3, Pp 283-285 (2022)
Externí odkaz:
https://doaj.org/article/c088a981f2424dce9c8f5a4939e35718
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 14, p 4868 (2023)
Purpose: This study aimed to investigate whether intravitreal aflibercept was safe and effective in patients with acute nonarteritic anterior ischemic optic neuropathy (NAION). Methods: This was a chart study of 25 individuals with acute NAION (25 ey
Externí odkaz:
https://doaj.org/article/77835907a6cb4c7fa77df591eb5492d2
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 7, p 1118 (2023)
This retrospective case-control study aimed to investigate associations between disease severity of Alzheimer’s dementia (AD) and macular thickness. Data of patients with AD who were under medication (n = 192) between 2013 and 2020, as well as an a
Externí odkaz:
https://doaj.org/article/8a3dc4ae9f344297b330cf3183114831
Autor:
Jung Lo, Hsin-En Wu, Ching-Chih Liu, Kun-Che Chang, Po-Yen Lee, Po-Len Liu, Shu-Pin Huang, Pei-Chang Wu, Tzu-Chieh Lin, Yu-Hung Lai, Yo-Chen Chang, Yuan-Ru Chen, Sheng-I Lee, Yu-Kai Huang, Shu-Chi Wang, Chia-Yang Li
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7300 (2023)
Microglia-associated neuroinflammation is recognized as a critical factor in the pathogenesis of neurodegenerative diseases; however, there is no effective treatment for the blockage of neurodegenerative disease progression. In this study, the effect
Externí odkaz:
https://doaj.org/article/1399ac2f79764234bc1f06d12478eb00
Publikováno v:
Vaccines, Vol 11, Iss 2, p 365 (2023)
A 25-year-old female with diabetes and hypertension presented with progressive painless blurred vision in her left eye ten days after she received her third dose of the SARS-CoV-2 mRNA vaccine BNT162b2 (Pfizer-BioNTech). The clinical examination conf
Externí odkaz:
https://doaj.org/article/ac5ba96e8ca74876ba22dce495a96713